GURUFOCUS.COM » STOCK LIST » USA » NAS » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Non Interest Income
Switch to:

Virax Biolabs Group (NAS:VRAX) Non Interest Income

View and export this data going back to 2022. Start your Free Trial

Non Interest Income only applies to banks.

Virax Biolabs Group (NAS:VRAX) Business Description

Virax Biolabs Group logo
Comparable Companies
Traded in Other Exchanges
30 Broadwick Street, London, GBR, W1F 8JB
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.